Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Levetiracetam NDC 50090-2815 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

str - 7316b619 c812 4279 8c99 1105f0ff3508 01

str - 7316b619 c812 4279 8c99 1105f0ff3508 01

fig 1 - 7316b619 c812 4279 8c99 1105f0ff3508 02

fig 1 - 7316b619 c812 4279 8c99 1105f0ff3508 02

fig 2 - 7316b619 c812 4279 8c99 1105f0ff3508 03

fig 2 - 7316b619 c812 4279 8c99 1105f0ff3508 03

This table represents the percentage of patients in a clinical trial receiving different doses of Levetiracetam compared to a placebo. The doses tested were 1000 mg/day and 2000 mg/day. There were 111 patients who received the placebo, 106 patients who received the 1000mg/day dose of Levetiracetam and 105 patients who received the 2000mg/day dose of Levetiracetam. The percentages indicate the portion of patients who received each treatment, but the purpose of the study or other results are not provided in the text.*

fig 3 - 7316b619 c812 4279 8c99 1105f0ff3508 04

fig 3 - 7316b619 c812 4279 8c99 1105f0ff3508 04

fig 4 - 7316b619 c812 4279 8c99 1105f0ff3508 05

fig 4 - 7316b619 c812 4279 8c99 1105f0ff3508 05

This appears to be a table showing the percentages of patients in a medical study who were either on a placebo or taking a medication called Levetiracetam. The percentages range from 20% to 45%, but there is not enough information to determine what the percentage represents. The table also includes symbols such as %, @, and ®.*

5 - 7316b619 c812 4279 8c99 1105f0ff3508 06

5 - 7316b619 c812 4279 8c99 1105f0ff3508 06

fig 6 - 7316b619 c812 4279 8c99 1105f0ff3508 07

fig 6 - 7316b619 c812 4279 8c99 1105f0ff3508 07

This appears to be a part of a statistical presentation, showing the percentage of patients in a placebo group and a group treated with Levetiracetam. However, without additional information or context, it is not possible to determine the purpose of this presentation or the significance of the numbers provided.*

logo - 7316b619 c812 4279 8c99 1105f0ff3508 08

logo - 7316b619 c812 4279 8c99 1105f0ff3508 08

logo - 7316b619 c812 4279 8c99 1105f0ff3508 09

logo - 7316b619 c812 4279 8c99 1105f0ff3508 09

Label Image - lbl500902815

Label Image - lbl500902815

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.